Theragen Bio is a company that leads precision medicine, which will be highlighted as a new paradigm of future medicine of Korea in the era of the Fourth Industrial Revolution. The company provides a wide range of services such as customized diagnostic solutions and next-generation sequencing (NGS), clinical and medical big data business based on state-of-the-art genome sequencing and analysis technologies.
Address:AICT bldg. A, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si Gyeonggi-do 16229, South Korea
- (31.Jul.2020) Theragen Bio Analyzes Largest Covid-19 Patient Data in Korea
- (27.Jul.2020) Theragen Bio Signs “Genetic Big Data” Research Agreement with Sungkyunkwan University
- (27.Jul.2020) Theragen Bio Successfully Analyzed the Dielectric Substances of Covid-19 and the Patients on the Largest Scale in Korea
- (06.May.2020) Theragen Bio Starts as Independent Company